Article info
PDFResearch ethics
Paper
The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Correspondence to Dr Franklin G Miller, Department of Bioethics, National Institutes of Health, 10 Center Drive, Bldg. 10, rm 1C118, Bethesda, MD 20892-1156, USA; FMiller{at}cc.nih.gov
Citation
The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
Publication history
- Received August 21, 2012
- Revised November 1, 2012
- Accepted November 19, 2012
- First published December 13, 2012.
Online issue publication
July 31, 2016
Article Versions
- Previous version (30 July 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
Other content recommended for you
- Placebo effects in trials evaluating 12 selected minimally invasive interventions: a systematic review and meta-analysis
- To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials
- Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls
- Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease
- Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
- Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
- Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- Placebo effects and the molecular biological components involved
- Placebo effects and racial and ethnic health disparities: an unjust and underexplored connection